Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04077658 · ClinicalTrials.gov registry record · NA
Heartmath Migraine Study
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT04077658 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 52 participants.
The verdict
NCT04077658, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This is a two arm study comparing smartphone based heart rate variability biofeedback using the HeartMath app and InnerBalance sensor to waitlist control on migraine quality of life.
Interventions
- BEHAVIORAL Waitlist Control
- BEHAVIORAL HeartMath
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2019-06-16 |
| Est. Completion | 2020-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04077658
The ClinicalTrials.gov registry entry for NCT04077658 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Waitlist Control is the first listed.
NCT04077658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04077658 about?
NCT04077658 is a clinical study titled "Heartmath Migraine Study". This is a two arm study comparing smartphone based heart rate variability biofeedback using the HeartMath app and InnerBalance sensor to waitlist control on migraine quality of life.
What is the current status of trial NCT04077658?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2019-06-16. Estimated completion is 2020-01-16.
What interventions are being tested in trial NCT04077658?
The interventions under investigation include: Waitlist Control (BEHAVIORAL), HeartMath (BEHAVIORAL).
Who is sponsoring clinical trial NCT04077658?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.